⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 13, 2024International Journal of Drug PolicyOpen Access

Changes in the incidence of cannabis-related disorders after the Cannabis Act and the COVID-19 pandemic in Québec, Canada

Pablo Martínez Chris Huynh Victoria Massamba Isaora Zefania Louis Rochette Helen-Maria Vasiliadis José Ignacio Nazif-Munoz

View Full Paper

Ask AI

Bookmark

Share

Abstract

The Canadian Cannabis Act (CCA, implemented in October 2018) and the COVID-19 pandemic (April 2020) might have contributed to cannabis-related harms in Québec, known for its stringent cannabis legal framework. We explored changes in incidence rates of cannabis-related disorders (CRD) diagnoses associated with these events in Québec.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Martínez et al. (2024) studied this question.

synapsesocial.com/papers/68e64f79b6db6435875dfb7a https://doi.org/10.1016/j.drugpo.2024.104484

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Changes in prenatal cannabis‐related diagnosed disorders after the Cannabis Act and the COVID‐19 pandemic in Quebec, Canada2024 · 6 citations
2Impact of Canada’s Cannabis Act on drug- and alcohol-related collisions in Québec: an interrupted time-series analysis of five major cities2025 · 1 citations
3Impact of Canada's cannabis legalisation on youth emergency department visits for cannabis‐related disorders and poisoning in Ontario and Alberta, 2015–2019Original Research · 2023 · 16 citations
4Trends in cannabis-attributable hospitalizations and emergency department visits: data from the Canadian Substance Use Costs and Harms Study (2007–2020)Original Research · 2025 · 2 citations
5The Relationship Between Rates of Cannabis Use and Covid-19 Infection Rates During the Pandemic: An Analysis of Canada’s National Cannabis Survey2024